In vivo and in vitro irreversible binding of hexamethylmelamine to liver and ovarian tumor macromolecules of mice.

作者信息

Garattini E, Donelli M G, Colombo T, Paesani R, Pantarotto C

出版信息

Biochem Pharmacol. 1981 May 15;30(10):1151-4. doi: 10.1016/0006-2952(81)90458-5.

DOI:10.1016/0006-2952(81)90458-5

PMID:6789835

Abstract

摘要

相似文献

In vivo and in vitro irreversible binding of hexamethylmelamine to liver and ovarian tumor macromolecules of mice.

Biochem Pharmacol. 1981 May 15;30(10):1151-4. doi: 10.1016/0006-2952(81)90458-5.

Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.

Cancer Treat Rep. 1981 Jul-Aug;65(7-8):669-72.

Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma.

Cancer Chemother Pharmacol. 1983;11(1):51-5. doi: 10.1007/BF00257418.

Biochemical studies on the ability of pentamethylmelamine to interact in vivo with DNA and proteins in a sensitive murine ovarian reticular cell sarcoma.

Biochem Pharmacol. 1984 Sep 1;33(17):2715-22. doi: 10.1016/0006-2952(84)90686-5.

Metabolic activation of hexamethylmelamine and pentamethylmelamine by liver microsomal preparations.

Life Sci. 1981 Oct 12;29(15):1591-8. doi: 10.1016/0024-3205(81)90261-7.

N-Hydroxymethylpentamethylmelamine, a major in vitro metabolite of hexamethylmelamine.

Life Sci. 1980 Jan 14;26(2):147-54. doi: 10.1016/0024-3205(80)90059-4.

Role of N-methylolpentamethylmelamine in the metabolic activation of hexamethylmelamine.

Cancer Res. 1983 Feb;43(2):500-4.

In vivo studies with hexamethylmelamine.

Eur J Cancer (1965). 1978 Jun;14(6):713-20. doi: 10.1016/0014-2964(78)90308-0.

Influence of ascites on the pharmacokinetics of hexamethylmelamine and N-demethylated metabolites in ovarian cancer patients.

Eur J Cancer Clin Oncol. 1981 Dec;17(12):1331-5. doi: 10.1016/0014-2964(81)90016-5.

Effect of cimetidine and ranitidine on the metabolism and toxicity of hexamethylmelamine.

Cancer Treat Rep. 1986 Dec;70(12):1443-5.

引用本文的文献

Clinical pharmacokinetics of altretamine.

Clin Pharmacokinet. 1995 Jun;28(6):439-48. doi: 10.2165/00003088-199528060-00002.

Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.

Drugs. 1995 Jun;49(6):932-53. doi: 10.2165/00003495-199549060-00007.

Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma.

Cancer Chemother Pharmacol. 1983;11(1):51-5. doi: 10.1007/BF00257418.

Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.

Cancer Chemother Pharmacol. 1985;15(1):49-53. doi: 10.1007/BF00257294.

Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumors.

Cancer Chemother Pharmacol. 1988;22(4):282-8. doi: 10.1007/BF00254232.

Active drug metabolites. An overview of their relevance in clinical pharmacokinetics.

Clin Pharmacokinet. 1985 May-Jun;10(3):216-27. doi: 10.2165/00003088-198510030-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验